91 related articles for article (PubMed ID: 20129639)
1. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
Lace MJ; Anson JR; Haugen TH; Turek LP
Virology; 2010 Apr; 399(2):270-9. PubMed ID: 20129639
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression.
Lee SH; Kim JW; Lee HW; Cho YS; Oh SH; Kim YJ; Jung CH; Zhang W; Lee JH
Oncogene; 2003 Jan; 22(3):381-91. PubMed ID: 12545159
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
7. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
[TBL] [Abstract][Full Text] [Related]
8. Gene structures and promoter characteristics of interferon regulatory factor 1 (IRF-1), IRF-2 and IRF-7 from snakehead Channa argus.
Jia W; Guo Q
Mol Immunol; 2008 Apr; 45(8):2419-28. PubMed ID: 18291530
[TBL] [Abstract][Full Text] [Related]
9. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.
Lace MJ; Anson JR; Klingelhutz AJ; Harada H; Taniguchi T; Bossler AD; Haugen TH; Turek LP
Carcinogenesis; 2009 Aug; 30(8):1336-44. PubMed ID: 19541854
[TBL] [Abstract][Full Text] [Related]
11. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity.
Lembo D; Donalisio M; De Andrea M; Cornaglia M; Scutera S; Musso T; Landolfo S
FASEB J; 2006 Jan; 20(1):148-50. PubMed ID: 16254045
[TBL] [Abstract][Full Text] [Related]
12. Interaction between interferon regulatory factor-1 and human papillomavirus E7 oncogene in cervical cancer: an ontology study.
Wiwanitkit V
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):138-41. PubMed ID: 19574175
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
14. The first intron of the human alpha2(I) collagen gene (COL1A2) contains a novel interferon-gamma responsive element.
Tanaka S; Ramirez F
Matrix Biol; 2007 Apr; 26(3):185-9. PubMed ID: 17142024
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
16. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.
Sgarbanti M; Marsili G; Remoli AL; Ridolfi B; Stellacci E; Borsetti A; Ensoli B; Battistini A
Ann N Y Acad Sci; 2004 Dec; 1030():187-95. PubMed ID: 15659797
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
19. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
20. A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.
Zhao W; Chow LT; Broker TR
Virology; 1999 Jan; 253(2):219-29. PubMed ID: 9918880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
